You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Arsenic trioxide for treating acute promyelocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA526
  • Published:  13 June 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 226 KB)

    Published:
    13 June 2018

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 333 KB)

    Published:
    04 May 2018
  • Committee papers (PDF 14.85 MB)

    Published:
    04 May 2018
  • Public committee slides (PDF 821 KB)

    Published:
    04 May 2018

Invitation to participate

  • Final scope (PDF 234 KB)

    Published:
    12 October 2017
  • Final matrix (PDF 299 KB)

    Published:
    12 October 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 350 KB)

    Published:
    12 October 2017
  • Equality impact assessment (Scoping) (PDF 192 KB)

    Published:
    12 October 2017
Back to top